The ROE as of December 2024 (TTM) for Aldeyra Therapeutics, Inc. (ALDX) is -43.01%

According to Aldeyra Therapeutics, Inc.’s latest financial reports and current stock price. The company's current ROE is -43.01%. This represents a change of 274.06% compared to the average of -11.50% of the last 4 quarters.

Aldeyra Therapeutics, Inc. (ALDX) Historical ROE (quarterly & annually)

How has ALDX ROE performed in the past?

The mean historical ROE of Aldeyra Therapeutics, Inc. over the last ten years is -60.92%. The current -43.01% ROE has changed -29.40% with respect to the historical average. Over the past ten years (40 quarters), ALDX's ROE was at its highest in in the December 2023 quarter at -3.97%. The ROE was at its lowest in in the December 2014 quarter at -38.90%.

Aldeyra Therapeutics, Inc. (ALDX) ROE by Quarter and Year

Discovering the peaks and valleys of Aldeyra Therapeutics, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Aldeyra Therapeutics, Inc. (ALDX) Average ROE

How has ALDX ROE performed in the past?

The current ROE of Aldeyra Therapeutics, Inc. (ALDX) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Aldeyra Therapeutics, Inc. (ALDX) ROE vs. Peers

How is ALDX’s ROE compared to its peers?

Aldeyra Therapeutics, Inc.’s ROE is greater than Tarsus Pharmaceuticals, Inc. (-55.86%), greater than LianBio (-21.53%), greater than Travere Therapeutics, Inc. (-541.59%), greater than Eton Pharmaceuticals, Inc. (-36.29%), greater than Viridian Therapeutics, Inc. (-45.47%), greater than Terns Pharmaceuticals, Inc. (-32.76%), greater than Structure Therapeutics Inc. (-16.40%), greater than Blueprint Medicines Corporation (-47.66%), greater than 89bio, Inc. (-59.58%), greater than X4 Pharmaceuticals, Inc. (-32.51%), greater than Inozyme Pharma, Inc. (-88.42%), greater than Day One Biopharmaceuticals, Inc. (-22.40%), greater than HOOKIPA Pharma Inc. (-49.25%), less than Phathom Pharmaceuticals, Inc. (211.43%), greater than Lyra Therapeutics, Inc. (-178.68%), greater than Cullinan Oncology, Inc. (-26.54%), greater than BioLineRx Ltd. (-163.37%), greater than Ardelyx, Inc. (-46.60%), greater than Lexicon Pharmaceuticals, Inc. (-107.38%), less than Seres Therapeutics, Inc. (60.75%), less than ImmunityBio, Inc. (86.39%),

Build a custom stock screener for Aldeyra Therapeutics, Inc. (ALDX) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Aldeyra Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Aldeyra Therapeutics, Inc. (ALDX) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Aldeyra Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.